Production of oxidants in alveolar macrophages and blood leukocytes

European Respiratory Journal

Volumn 14, Issue 5, 1999, Pages 1100-1105

  Haugen, T S ^a   Skjonsberg O H ^a   Kahler H ^a   Lyberg, T ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alveolar macrophages; Monocytes; Oxidants; Polymorphonuclear neutrophils

Indexed keywords

OXIDIZING AGENT;

ARTICLE; CELL ACTIVATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MONOCYTE; OXIDATIVE STRESS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0032743811     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14511009     Document Type: Article

References (41)

1. Lohmann-Matthes M-L, Steinmüller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
2. Maier KL. How the lung deals with oxidants. Eur Respir J 1993; 6: 334-336.
3. Doelman CJA, Bast A. Oxygen radicals in lung pathology. Free Rad Biol 1990; 9: 381-400.
4. Schraufstätter IU, Cochrane CG. Oxidants: types, sources, and mechanisms of injury. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. Philadelphia, Raven Publishers, 1997; pp. 2251-2257.
5. Chabot F, Mitchell JA, Gutteridge JMC, Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 1998; 11: 745-757.
6. Schaberg T, Rau M, Stephan H, Lode H. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Am Rev Respir Dis 1993; 147: 1507-1513.
7. Majori M, Vachier I, Godard P, Farce M, Bousquet J, Chanez P. Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur Respir J 1998; 11: 133-138.
8. Vachier I, Chanez P, Le Doucen C, Damon M, Descomps B, Godard P. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994; 7: 1585-1592.
9. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271: 40-47.
10. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992; 298: 446-451.
11. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-1254.
12. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94: 2407-2413.
13. Ischiropoulos H, Al-Mehdi AB, Fischer AB. Reactive species in ischemic rat lung injury; contribution of peroxynitrite. Am J Physiol (Lung Cell Mol Physiol) 1995; 269: L158-L164.
14. Calhoun WJ, Reed HE, Moest DR, Stevens CA. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992; 145: 317-325.
15. Kuo HP, Yu CT. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis. Chest 1993; 104: 1773-1778.
16. Nakstad B, Lyberg T, Skjørten F, Boye NP. Subpopulations of human lung alveolar macrophages: ultrastructural features. Ultrastruct Pathol 1989; 13: 1-3.
17. Brannen AL, Chandler DB. Alveolar macrophage subpopulations' responsiveness to chemotactic stimuli. Am J Pathol 1988; 132: 161-165.
18. Rothberger H, McGee MP, Lee T-K. Tissue factor activity. A marker of alveolar macrophage maturation in rabbits. Effects of granulomatous pneumonitis. J Clin Invest 1984; 73: 1524-1531.
19. Idell S, Cohen AB. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin Chest Med 1985; 6: 459-471.
20. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. New Engl J Med 1984; 310: 154-166.
21. Hance AJ, Douchess S, Winchester RJ, Ferrans VJ, Crystal RG. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 1985; 134: 284-292.
22. Perticarari S, Presani G, Banfi E. A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 1994; 170: 117-124.
23. Shapiro HM. Practical flow cytometry. 3rd Edn. New York, Wiley-Liss, John Wiley & Sons Inc., 1995; pp. 318-319.
24. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994; 16: 149-156.
25. Haslam PL, Parker DJ, Townsend PJ. Increases in HLA-DQ, DP, DR and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis. Chest 1990; 97: 651-661.
26. Wassermann K, Subklewe M, Pothoff G, Banik N, Schell-Frederick E. Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometry. Chest 1994; 105: 1324-1334.
27. Kienast K, Müller-Quernheim J, Knorst M, Lubjuhn S, Ferlinz R. In vitro study of human alveolar macrophage and peripheral blood mononuclear cell reactive oxygen-intermediates release induced by sulfur dioxide at different concentrations. Lung 1994; 172: 335-345.
28. Kienast K, Knorst M, Lubjuhn S, Müller-Quernheim J, Ferlinz R. Nitrogen dioxide-induced reactive oxygen intermediates production by human alveolar macrophages and peripheral blood mononuclear cells. Arch Environment Health 1994; 49: 246-250.
29. Kemmerich B, Rossing TH, Pennington JE. Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon. Am Rev Respir Dis 1987; 136: 266-270.
30. Klebanoff SJ. Phagocytic cells: products of oxygen metabolism. In: Gallin JI, Goldstein W, Snyderman R, eds. Inflammation: Basic principles and clinical correlates. New York, Raven Press Ltd., 1988; pp. 391-444.
31. Holian A, Dauber JH, Diamond MS, Daniele RP. Separation of bronchoalveolar cells from the guinea pig on continuous gradients of Percoll: functional properties of fractionated lung macrophages. J Reticuloend Soc 1983; 33: 157-164.
32. Calhoun WJ, Salisbury SM. Heterogeneity in cell recovery and superoxide production in buoyant, density-defined subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients. J Lab Clin Med 1989; 114: 682-690.
33. Zeidler RB, Yarbro JW, Conley NS. Bleomycin increases superoxide production in the most active alveolar macrophage subpopulation. Int J Immunopharmac 1987; 9: 691-696.
34. Schaberg T, Klein U, Rau M, Eller J, Lode H. Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production. Am J Respir Crit Care Med 1995; 151: 1551-1558.
35. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 1995; 270: 16542-16548.
36. Gillissen A, Bartling A, Schoen S, Schultze-Werninghaus G. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung 1997; 175: 235-242.
37. Strausz J, Müller-Quernheim J, Steppling H, Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1990; 141: 124-128.
38. Brown MA, Lantz RC, Sobonya R, Devine LC, Lentz LA, Lernen RJ. Aerosolized lipopolysaccharide increases pulmonary clearance of 99mTc-DTPA in rabbits. Am Rev Respir Dis 1992; 146: 1462-1468.
39. Sibille Y, Marchandise F-X. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J 1993; 6: 1529-1543.
40. Gatti S, Faggioni R, Echtenacher B, Ghezzi P. Role of tumor necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 1993; 91: 456-461.
41. Tsuji C, Minhaz MU, Shioya S, Fukahori M, Tanigaki T, Nakazawa H. The importance of polymorphonuclear leukocytes in lipopolysaccharide-induced superoxide anion production and lung injury: ex vivo observation in rat lungs. Lung 1997; 176: 1-13.